PURETECH HEALTH PLC Research and Development Expense
PURETECH HEALTH PLC (PRTCY) reported Research and Development Expense of $69.45 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-04-30
| Period end | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|
| 2024-12-31 | $69.45M 20-F · filed 2025-04-30 | |
| 2024-06-30 | $38.93M 6-K · filed 2024-08-28 | |
| 2023-12-31 | $96.23M 20-F · filed 2025-04-30 | |
| 2023-06-30 | $53.15M 6-K · filed 2024-08-28 | |
| 2022-12-31 | $152.43M 20-F · filed 2025-04-30 | |
| 2021-12-31 | $110.47M 20-F · filed 2024-04-25 | |
| 2020-12-31 | $81.86M 20-F · filed 2023-04-28 | |
| 2019-12-31 | $85.85M 20-F · filed 2022-04-26 | |
| 2018-12-31 | $77.40M 20-F · filed 2021-04-15 |